Xu Chen
12PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Mar 31, 2026
Miniature and versatile genome regulation TnpB-ωRNA toolkits facilitate cancer immunotherapy.Junlin Lu, Jiajian Lai, Liang Cheng
|Aug 26, 2025
Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy.Hengji Zhan, Hongjin Wang, Bolin Pan
|Jul 17, 2025
Heat shock factor 1 promotes proliferation and chemoresistance in diffuse large B-cell lymphoma by enhancing the cell cycle and DNA repair.Yu Fang, Liang Cheng, Ming Huang
|Jul 15, 2025
Intravesical Disitamab Vedotin (RC48) for HER2-Expressing High-Risk Non-Muscle-Invasive Bladder Cancer: A Single-Arm, Dose-Escalation Phase I Trial Study.Xu Chen, Ming Huang, Zehua Chen
|Jun 18, 2025
A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy.Chengjunyu Zhang, Sen Liu, Jianhui Zhang
|Jun 11, 2025
Engineering CRISPR System-Based Bacterial Outer Membrane Vesicle Potentiates T Cell Immunity for Enhanced Cancer Immunotherapy.Hongjin Wang, Hengji Zhan, Bolin Pan
Pageof 2
